Prevalence of Macro-vascular Complications Among Type 2 Diabetic Adults Aged 50 and Over: Results from Ardakan Cohort Study on Aging (ACSA)

Overview

Journal J Diabetes Metab Disord

Date 2025 Jan 13

PMID 39801689

Authors

Mariye Jenabi Ghods

Alireza Amirabadizadeh

Ahmad Delbari

Mahshad Naserpour

Mohammad Saatchi

Affiliations

Soon will be listed here.

Abstract

Objective: Type 2 diabetes mellitus (T2DM) is a common condition that can lead to adverse macrovascular complications. This study aims to determine the prevalence of macrovascular complications in adults aged ≥ 50 with T2DM in Ardakan city, using data from the Ardakan Cohort Study on Aging (ACSA).

Methods: A cross-sectional investigation involved 5933 participants from the ACSA; of those assessed, 2340 had T2DM. Macrovascular complications, specifically coronary artery disease (CAD), cerebrovascular disease (CVD), and peripheral artery disease(PAD) were identified through medical records and physician assessment. Logistic regression was used to identify risk factors for these complications.

Results: The prevalence of CAD and CVD were 16.9% (95% CI:16.0-19.0) and 4% (95% CI:3.3-5.0), respectively. risk factors for CAD included age over 60 (OR = 1.47, 95% CI: 1.08-2.01, = 0.01), male gender (OR = 1.87, 95% CI: 1.33-2.62, < 0.001), former smoking (OR = 1.96, 95% CI: 1.30-2.95, = 0.001), hypertension (OR = 3.16, 95% CI: 2.23-4.46, < 0.001), and over ten years of diabetes duration(OR = 2.04, 95% CI: 1.39-2.99, < 0.001) and For CVD, significant risk factors included male gender (OR = 2.61, 95% CI: 1.52-4.51, = 0.001) and hypertension (OR = 2.36, 95% CI: 1.27-4.39, = 0.006).

Conclusion: This study highlights the high prevalence of macrovascular complications in adults over 50 with T2DM in Ardakan. It emphasizes the importance of managing key risk factors such as hypertension and quitting smoking, especially in older adults and males.

References

Templer S, Abdo S, Wong T . Preventing diabetes complications. Intern Med J. 2024; 54(8):1264-1274. DOI: 10.1111/imj.16455. View

Korytkowski M, Forman D . Management of Atherosclerotic Cardiovascular Disease Risk Factors in the Older Adult Patient With Diabetes. Diabetes Care. 2017; 40(4):476-484. DOI: 10.2337/dc16-0815. View

Maida C, Daidone M, Pacinella G, Norrito R, Pinto A, Tuttolomondo A . Diabetes and Ischemic Stroke: An Old and New Relationship an Overview of the Close Interaction between These Diseases. Int J Mol Sci. 2022; 23(4). PMC: 8877605. DOI: 10.3390/ijms23042397. View

Canto E, Ceriello A, Ryden L, Ferrini M, Hansen T, Schnell O . Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications. Eur J Prev Cardiol. 2019; 26(2_suppl):25-32. DOI: 10.1177/2047487319878371. View

Vecchie A, Montecucco F, Carbone F, Dallegri F, Bonaventura A . Diabetes and Vascular Disease: Is It All About Glycemia?. Curr Pharm Des. 2019; 25(29):3112-3127. DOI: 10.2174/1381612825666190830181944. View

Kieu A, King J, Govender R, Ostlundh L . The Benefits of Utilizing Continuous Glucose Monitoring of Diabetes Mellitus in Primary Care: A Systematic Review. J Diabetes Sci Technol. 2022; 17(3):762-774. PMC: 10210096. DOI: 10.1177/19322968211070855. View

van Mark G, Tittel S, Sziegoleit S, Putz F, Durmaz M, Bortscheller M . Type 2 diabetes in older patients: an analysis of the DPV and DIVE databases. Ther Adv Endocrinol Metab. 2020; 11:2042018820958296. PMC: 7509713. DOI: 10.1177/2042018820958296. View

An J, Nichols G, Qian L, Munis M, Harrison T, Li Z . Prevalence and incidence of microvascular and macrovascular complications over 15 years among patients with incident type 2 diabetes. BMJ Open Diabetes Res Care. 2021; 9(1). PMC: 7783518. DOI: 10.1136/bmjdrc-2020-001847. View

Fotouhi F, Rezvan F, Hashemi H, Javaherforoushzadeh A, Mahbod M, Yekta A . High prevalence of diabetes in elderly of Iran: an urgent public health issue. J Diabetes Metab Disord. 2022; 21(1):777-784. PMC: 9167264. DOI: 10.1007/s40200-022-01051-x. View

10.

Huang E, Laiteerapong N, Liu J, John P, Moffet H, Karter A . Rates of complications and mortality in older patients with diabetes mellitus: the diabetes and aging study. JAMA Intern Med. 2013; 174(2):251-8. PMC: 3950338. DOI: 10.1001/jamainternmed.2013.12956. View

11.

Tracey M, McHugh S, Fitzgerald A, Buckley C, Canavan R, Kearney P . Risk Factors for Macro- and Microvascular Complications among Older Adults with Diagnosed Type 2 Diabetes: Findings from The Irish Longitudinal Study on Ageing. J Diabetes Res. 2016; 2016:5975903. PMC: 4884580. DOI: 10.1155/2016/5975903. View

12.

Jalilian H, Javanshir E, Torkzadeh L, Fehresti S, Mir N, Heidari-Jamebozorgi M . Prevalence of type 2 diabetes complications and its association with diet knowledge and skills and self-care barriers in Tabriz, Iran: A cross-sectional study. Health Sci Rep. 2023; 6(2):e1096. PMC: 9895320. DOI: 10.1002/hsr2.1096. View

13.

Hong S, Park J, Han K, Lee C, Kim D, Yu S . Association Between Obesity and Cardiovascular Disease in Elderly Patients With Diabetes: A Retrospective Cohort Study. J Clin Endocrinol Metab. 2021; 107(2):e515-e527. DOI: 10.1210/clinem/dgab714. View

14.

Wakui N, Ozawa M, Yanagiya T, Endo S, Togawa C, Matsuoka R . Factors Associated With Medication Compliance in Elderly Patients With Type 2 Diabetes Mellitus: A Cross-Sectional Study. Front Public Health. 2022; 9:771593. PMC: 8787062. DOI: 10.3389/fpubh.2021.771593. View

15.

Esteghamati A, Larijani B, Haji Aghajani M, Ghaemi F, Kermanchi J, Shahrami A . Diabetes in Iran: Prospective Analysis from First Nationwide Diabetes Report of National Program for Prevention and Control of Diabetes (NPPCD-2016). Sci Rep. 2017; 7(1):13461. PMC: 5647418. DOI: 10.1038/s41598-017-13379-z. View

16.

Vetter V, Spieker J, Sommerer Y, Buchmann N, Kalies C, Regitz-Zagrosek V . DNA methylation age acceleration is associated with risk of diabetes complications. Commun Med (Lond). 2023; 3(1):21. PMC: 9918553. DOI: 10.1038/s43856-023-00250-8. View

17.

Paulus W, Canto E . Distinct Myocardial Targets for Diabetes Therapy in Heart Failure With Preserved or Reduced Ejection Fraction. JACC Heart Fail. 2017; 6(1):1-7. DOI: 10.1016/j.jchf.2017.07.012. View

18.

Lin T, Leu H . Association of Body Mass Index and Clinical Outcomes in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention. Acta Cardiol Sin. 2025; 41(1):82-93. PMC: 11701491. DOI: 10.6515/ACS.202501_41(1).20241021B. View

19.

Wang T, Zhang X, Liu J . Long-Term Glycemic Variability and Risk of Cardiovascular Events in Type 2 Diabetes: A Meta-Analysis. Horm Metab Res. 2022; 54(2):84-93. DOI: 10.1055/a-1730-5029. View

20.

Cigolle C, Blaum C, Lyu C, Ha J, Kabeto M, Zhong J . Associations of Age at Diagnosis and Duration of Diabetes With Morbidity and Mortality Among Older Adults. JAMA Netw Open. 2022; 5(9):e2232766. PMC: 9526092. DOI: 10.1001/jamanetworkopen.2022.32766. View